The company has committed to donate up to 500,000 doses of an investigational Janssen vaccine regimen to help protect citizens of the Democratic Republic of the Congo—the site of the world’s second largest outbreak of the disease.
From a $10 million pledge to UNICEF in support of health workers to promising news about a preventive HIV vaccine regimen, the company’s new 2018 Health for Humanity Report details how Johnson & Johnson is dedicated to creating a better future for everyone, everywhere.
With company leaders at the World Economic Forum in Davos this week, Johnson & Johnson’s Chief Scientific Officer weighs in on the next great global healthcare challenge—and how we can all come together to help address it.
The company has once again been recognized for its commitment to employees, innovation and the health and well-being of people around the world.
Stopping pandemics before they strike: What you need to know about the Coalition for Epidemic Preparedness Innovations
Johnson & Johnson’s Chief Medical Officer for Global Public Health had a front row seat at the World Economic Forum this year as part of a new coalition aimed at helping to advance vaccine development for pathogens.